Net Loss of Piramal Pharma reported to Rs 88.64 crore in the quarter ended June 2024 as against net loss of Rs 98.58 crore during the previous quarter ended June 2023. Sales rose 11.57% to Rs 1951.14 crore in the quarter ended June 2024 as against Rs 1748.85 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 1951.14 | 1748.85 | 12 |
| OPM % | 10.48 | 7.57 | - |
| PBDT | 139.47 | 66.50 | 110 |
| PBT | -45.08 | -107.11 | 58 |
| NP | -88.64 | -98.58 | 10 |